@article{7314aaa4e4694aa5889716976ea0def6,
title = "Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group",
keywords = "Humans, Retrospective Studies, Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics, Gene Rearrangement, MEF2 Transcription Factors, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/genetics",
author = "Kentaro Ohki and Butler, \{Ellie R.\} and Nobutaka Kiyokawa and Shinsuke Hirabayashi and Bergmann, \{Anke K.\} and Anja M{\"o}ricke and Boer, \{Judith M.\} and H{\'e}l{\`e}ne Cav{\'e} and Giovanni Cazzaniga and Yeoh, \{Allen Eng Juh\} and Masashi Sanada and Toshihiko Imamura and Hiroto Inaba and Mullighan, \{Charles G.\} and Loh, \{Mignon L.\} and Ulrika Nor{\'e}n-Nystr{\"o}m and Shih, \{Lee Yung\} and Marketa Zaliova and Pui, \{Ching Hon\} and Haas, \{Oskar A.\} and Harrison, \{Christine J.\} and Moorman, \{Anthony V.\} and Atsushi Manabe",
note = "Funding Information: Research support: We acknowledge funding from Clinical Cancer Research from the Ministry of Health, Labour and Welfare, Japan; Japan Agency for Medical Research and Development (AMED), Japan; Blood Cancer UK (15036); National Cancer Institute (CA021765), US; Czech Health Research Council project NU20-07-00322; ERA-NET TRANSCAN EJC granted by Foundation ARC, France; Center for Biological Resources (CRB-cancer; BB-0033-00076), Robert Debr{\'e} Hospital, France; Oncode Institute and KiKa Foundation, Netherlands; American and Lebanese Syrian Associated Charities of St. Jude Children{\textquoteright}s Research Hospital (HI, CGM, C-HP), US National Cancer Institute R35 CA297695 (CGM). We thank the following additional study group members for their support. AIEOP: Valentino Conter, Andrea Biondi; Polish ALIC: Wojciech Mlynarski; BFM-A: Georg Mann, Andishe Attarbaschi, Karin Nebral, Sabine Strehl and Dagmar Schinnerl; BFM-G/CH: Martin Schrappe; COG: Stephen Hunger; DCOG: Rob Pieters; JACLS: Junichi Hara, Keizo Horibe; NOPHO: Kjeld Schmiegelow, Mats Heyman; TCCSG: Akira Ohara, Katsuyoshi Koh; TPOG: His-Che Liu; CLIP: Jan Stary; UKALL: Ajay Vora, Claire Schwab; SFCE: Chlo{\'e} Arfeuille, Aur{\'e}lie Caye-Eude, Andr{\'e} Baruchel, Yves Bertrand, Pierre Rohrlich, Marion Strullu. Funding Information: CGM: Research support from Loxo, Abbvie, Pfizer. Consulting and speaking fees from Amgen, Illumina. C-HP received consulting and speaker fees from Amgen, Erytech Phamra, and Servier. HI received a research grant from Servier. AVM: Honoria for speaking from Amgen. ",
year = "2023",
doi = "10.1038/s41375-022-01737-4",
language = "English",
volume = "37",
pages = "212--216",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Springer Nature",
number = "1",
}